ALBEMARLE CORP — fact timeline

Max W. Hood was appointed as Chief Accounting Officer at ALBEMARLE CORP.

“On August 19, 2026, the Board of Directors of Albemarle Corporation (the “Company”) appointed Max W. Hood as the Company’s Chief Accounting Officer, effective August 24, 2026.”

Eduardo De Salles Bartolomeo was appointed as Director at ALBEMARLE CORP.

“Effective as of July 21, 2026, the Board of Directors (the “Board”) of Albemarle Corporation (the “Company”) appointed Mr. Eduardo De Salles Bartolomeo as an independent member of the Board.”

Neal R. Sheorey was appointed as interim Principal Accounting Officer at ALBEMARLE CORP.

“Neal R. Sheorey, the Company's Executive Vice President and Chief Financial Officer, will serve as the Company's interim Principal Accounting Officer, effective June 2, 2026, until the Company’s Board of Directors appoints a replacement for the Company’s former Chief Accounting Officer.”

Donald J. LaBauve Jr. retired as Chief Accounting Officer at ALBEMARLE CORP.

“As previously reported, Donald J. LaBauve Jr., the former Chief Accounting Officer of Albemarle Corporation (the “Company”), retired on June 1, 2026.”

ALBEMARLE CORP shareholders approved Shareholder proposal regarding shareholder’ ability to call a special meeting at the 2026-05-05 meeting.

“Proposal 6 . S hareholder proposal . By the votes set forth below, the shareholders approved the shareholder proposal regarding shareholder’ ability to call a special meeting.”

ALBEMARLE CORP shareholders approved Approval of the Albemarle Corporation 2026 Incentive Plan at the 2026-05-05 meeting.

“Proposal 5. Approval of the Albemarle Corporation 2026 Incentive Plan. By the votes set forth below, the shareholders approved the Albemarle Corporation 2026 Incentive Plan.”

ALBEMARLE CORP shareholders rejected Amendment to the Articles of Incorporation to remove supermajority provisions related to affiliated transactions at the 2026-05-05 meeting.

“Proposal 4. Amendment to the Articles of Incorporation. By the votes set forth below, shareholders did not approve the amendment of the Company’s Articles of Incorporation to remove supermajority provisions related to affiliated transactions.”

ALBEMARLE CORP shareholders approved Ratification of appointment of independent registered public accounting firm at the 2026-05-05 meeting.

“Proposal 3 . Ratification of appointment of independent registered public accounting firm . By the votes set forth below, the shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

ALBEMARLE CORP shareholders approved Advisory vote on executive compensation at the 2026-05-05 meeting.

“Proposal 2 . Advisory vote on executive compensation . By the votes set forth below, the shareholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers, as set forth in the Proxy Statement.”

ALBEMARLE CORP shareholders approved Election of directors at the 2026-05-05 meeting.

“Proposal 1 . Election of directors . By the votes set forth in the table below, the shareholders elected all of the nominees for director to serve for a term expiring at the annual meeting of shareholders in 2027.”

ALBEMARLE CORP reported the first quarter ended March 31, 2026 results: revenue $1.4 billion, net income $319 million, EPS $2.34 per diluted share.

“quarter ended March 31, 2026. First Quarter 2026 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) • Net sales of $1.4 billion, up 33% due to higher volumes and pricing in Energy Storage (volumes +14%, price +51%) and Specialties (volumes +7%, price +2%). • Net income of $319 million, or $2.34 per”

ALBEMARLE CORP amended Third Amendment with Bank of America, N.A. (effective 2026-03-19).

“On March 19, 2026, Albemarle Corporation (the “Company”), Albemarle Europe Srl, the lenders party thereto and Bank of America, N.A., as administrative agent, entered into the third amendment (the “Third Amendment”) to that certain amended and restated credit agreement dated as of October 28, 2022”

ALBEMARLE CORP completed a disposition involving ChemCat AcquisitionCo, LLC for approximately $547 million in cash (closed 2026-03-02).

“arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,”

John C. Barichivich III departed as principal accounting officer at ALBEMARLE CORP.

“As previously announced, John C. Barichivich III will cease serving as the Company’s principal accounting officer upon the effective date of Mr. LaBauve’s appointment as his successor.”

Donald J. LaBauve, Jr. was appointed as Chief Accounting Officer at ALBEMARLE CORP.

“On October 28, 2024, Albemarle Corporation (the “Company”) appointed Donald J. LaBauve, Jr. (Jim) as the Company’s Chief Accounting Officer, effective November 11, 2024.”

John C. Barichivich III departed as Vice President, Corporate Controller and Chief Accounting Officer at ALBEMARLE CORP.

“In addition, in connection with the implementation of such new operating structure, John C. Barichivich III will cease serving as Vice President, Corporate Controller and Chief Accounting Officer of the Company effective upon the appointment of his successor, and his last day of employment will be December 31, 2024.”

Kristin Coleman departed as Executive Vice President, General Counsel and Corporate Secretary at ALBEMARLE CORP.

“On October 7, 2024, in connection with the implementation of the new operating structure described in Item 7.01 below, Kristin Coleman will cease serving as Executive Vice President, General Counsel and Corporate Secretary of Albemarle Corporation (the “Company”), and her last day of employment will be November 4, 2024.”

ALBEMARLE CORP: Increased authorized common shares from 150,000,000 to 275,000,000 (effective 2024-05-10).

“Albemarle Corporation (the “Company”) filed Articles of Amendment with the State Corporation Commission of the Commonwealth of Virginia (the “SCC”) to amend the Company’s Amended and Restated Articles of Incorporation (the “Charter”) to increase the number of authorized shares of common stock, $0.01 par value per share, from 150,000,000 to 275,000,000 (the “Charter Amendment”).”

ALBEMARLE CORP shareholders approved Ratification of appointment of independent registered public accounting firm at the 2024-05-07 meeting.

“Proposal 4 . Ratification of appointment of independent registered public accounting firm . The shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, by the votes set forth in the table below. Voted For Voted Against Abstain Broker Non-Votes 86,248,537 7,754,186 439,695 N/A”

ALBEMARLE CORP shareholders approved Charter Amendment to increase the number of authorized shares of common stock at the 2024-05-07 meeting.

“Proposal 3 . Charter Amendment to increase the number of authorized shares of common stock . The shareholders approved the Charter Amendment to increase the Company’s number of authorized shares of common stock by the votes set forth in the table below. Voted For Voted Against Abstain Broker Non-Votes 88,786,666 5,369,507 286,245 N/A”

ALBEMARLE CORP shareholders approved Advisory vote on executive compensation at the 2024-05-07 meeting.

“Proposal 2 . Advisory vote on executive compensation . The shareholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers, as set forth in the Proxy Statement, by the votes set forth in the table below. Voted For Voted Against Abstain Broker Non-Votes 67,682,378 11,136,388 1,705,771 13,917,881”

ALBEMARLE CORP shareholders approved Election of directors at the 2024-05-07 meeting.

“Proposal 1 . Election of directors . The shareholders elected all of the nominees for director to serve for a term expiring at the annual meeting of shareholders in 2025 by the votes set forth in the table below.”

ALBEMARLE CORP reported the first quarter ended March 31, 2024 results: revenue $1.4 billion, net income $2 million, or ($0.08) per diluted share attributable to common shareholders. Guidance reaffirmed.

“today announced its results for the first quarter ended March 31, 2024. First-Quarter 2024 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) • Net sales of $1.4 billion, driven by Energy Storage volume growth as projects ramp • Net income of $2 million, or ($0.08) (a) per diluted share attributable to common shareholders”

ALBEMARLE CORP: Filed Articles of Amendment to establish preferences, limitations and relative rights of Mandatory Convertible Preferred Stock (effective 2024-03-08).

“On March 7, 2024, the Company filed the Articles of Amendment with the SCC to establish the preferences, limitations and relative rights of the Mandatory Convertible Preferred Stock. The Articles of Amendment became effective upon the issuance of a Certificate of Amendment by the SCC to the Company on March 8, 2024.”

ALBEMARLE CORP entered into Deposit Agreement with Equiniti Trust Company, LLC (effective 2024-03-08).

“the Company entered into a deposit agreement (the “ Deposit Agreement ”), dated March 8, 2024, by and among the Company, Equiniti Trust Company, LLC, as depositary”

ALBEMARLE CORP entered into Articles of Amendment.

“the Company filed articles of amendment (the “ Articles of Amendment ”) to the Company’s Amended and Restated Articles of Incorporation with the State Corporation Commission of the Commonwealth of Virginia”

ALBEMARLE CORP entered into Underwriting Agreement with J.P. Morgan Securities LLC, as representative of the several underwriters (effective 2024-03-05).

“On March 5, 2024, Albemarle Corporation (the “Company”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with J.P. Morgan Securities LLC, as representative of the several underwriters named in Schedule 1 thereto”

ALBEMARLE CORP updated its full-year 2024 guidance (initiated).

“Introduced full-year 2024 outlook considerations, including Energy Storage ranges based on lithium market price scenarios and utilizing an updated adjusted EBITDA definition similar to that in the company's amended credit agreement”

ALBEMARLE CORP reported the full year ended December 31, 2023 results: revenue $9.6 billion, net income $1.6 billion, EPS $13.36 per diluted share.

“Net sales of $9.6 billion, the highest in company history, up 31%, of which 21% was total volume growth; Energy Storage sales volumes were up 35% • Net income of $1.6 billion, or $13.36 per diluted share, the second highest in company history”

ALBEMARLE CORP reported the fourth quarter ended December 31, 2023 results: revenue $2.4 billion, net income $618 million, EPS ($5.26) per diluted share.

“Net sales of $2.4 billion, primarily driven by 35% volume growth in Energy Storage • Net loss of $618 million, or ($5.26) per diluted share, including the LCM charge and tax valuation allowance expense”

ALBEMARLE CORP reported the third quarter ended September 30, 2023 results: revenue $2.3 billion, net income $302.5 million, or $2.57 per diluted share. Guidance reaffirmed.

“quarter ended September 30, 2023. Third-Quarter 2023 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) • Net sales of $2.3 billion, an increase of 10% • Net income of $302.5 million, or $2.57 per diluted share • Adjusted diluted EPS of $2.74 • Adjusted EBITDA of $453.3 million • Signed agreements with”

ALBEMARLE CORP: Amended and restated Bylaws to clarify procedural and disclosure requirements for shareholder director nominations under universal proxy rules and other technical revisions (effective 2023-10-23).

“On October 23, 2023, the Board amended and restated the Company’s Amended and Restated Bylaws (as amended, the “Bylaws”) to clarify and implement certain procedural and disclosure requirements for shareholders nominating individuals for election or reelection as directors at the Company’s annual or special meetings of shareholders in connection with the “universal proxy” rules adopted by the Securities and Exchange Commission pursuant to Rule 14a-19 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).”

Neal Sheorey was appointed as Executive Vice President and Chief Financial Officer at ALBEMARLE CORP.

“Mr. Tozier will be succeeded by Neal Sheorey, age 47, as Executive Vice President and Chief Financial Officer.”

Scott Tozier changed role as Executive Vice President and Chief Financial Officer at ALBEMARLE CORP.

“Scott Tozier, Executive Vice President and Chief Financial Officer, determined that Mr. Tozier will transition from his current role to serving in an advisory capacity as an employee of the Company, effective November 6, 2023”

ALBEMARLE CORP reported full-year 2023 results: revenue $10.4 - $11.5 billion, EPS $25.00 - $29.50. Guidance raised.

“FY 2023 Guidance as of August 2, 2023 Net sales $9.8 - $11.5 billion $10.4 - $11.5 billion Adjusted EBITDA (a) $3.3 - $4.0 billion $3.8 - $4.4 billion Adjusted EBITDA Margin (a) 34% - 35% 37% - 38% Adjusted Diluted EPS (a) $20.75 - $25.75 $25.00 - $29.50 Net Cash from Operations $1.7 - $2.3 billion $1.2 - $1.8 billion Capital Expenditures $1.7 - $1.9 billion $1.9 - $2.1 billion”

ALBEMARLE CORP reported the second quarter ended June 30, 2023 results: revenue $2.4 billion, net income $650.0 million, EPS $5.52 per diluted share.

“Net sales of $2.4 billion, an increase of 60% • Net income of $650.0 million, or $5.52 per diluted share, an increase of 60%”

ALBEMARLE CORP incurred debt of $1.5 billion maturing 397 days from the date of issuance.

“On May 17, 2023, Albemarle Corporation (the “Company”) entered into definitive documentation to increase the size of its existing commercial paper program that was initiated on May 29, 2013 (the “CP Program”), under which the Company may issue short-term, unsecured commercial paper notes (the “Notes”) pursuant to an exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). The maximum aggregate face amount of Notes outstanding at any time is $1.5 billion (up from $750 million prior to the increase). The Notes will be sold under customary market terms in the U.S. commercial paper market at a discount from par, or alternatively, at par and bear interest at rates that will vary based upon market conditions at the time of issuance . The maturities of the Notes may vary, but may not exceed 397 days from the date of issuance.”

ALBEMARLE CORP reported the first quarter ended March 31, 2023 results: revenue $2.6 billion, net income $1.2 billion, or $10.51 per diluted share, EPS $10.32. Guidance lowered.

“quarter ended March 31, 2023. First-Quarter 2023 and Recent Highlights (Unless otherwise stated, all percentage changes represent year-over-year comparisons) • Net sales of $2.6 billion, an increase of 129% • Net income of $1.2 billion, or $10.51 per diluted share, an increase of 389% • Adjusted diluted EPS of $10.32, an increase of 334% • Adjusted EBITDA of”

ALBEMARLE CORP shareholders approved Approval of the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors at the 2023-05-02 meeting.

“Proposal 5 . Approval of the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors . The shareholders approved the 2023 Stock Compensation and Deferral Election Plan for Non-Employee Directors, by the votes set forth in the table below. Voted For Voted Against Abstain Broker Non-Votes 89,290,093 1,668,896 142,854 10,459,292”

ALBEMARLE CORP shareholders approved Ratification of appointment of independent registered public accounting firm at the 2023-05-02 meeting.

“Proposal 4 . Ratification of appointment of independent registered public accounting firm . The shareholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, by the votes set forth in the table below. Voted For Voted Against Abstain Broker Non-Votes 95,541,169 5,951,315 68,651 N/A”

ALBEMARLE CORP shareholders approved Frequency of periodic advisory votes on executive compensation at the 2023-05-02 meeting.

“Proposal 3 . F requency of periodic advisory votes on executive compensation . The shareholders recommended, on a non-binding, advisory basis, annual frequency of future advisory votes on the compensation of our named executive officers, by the votes set forth in the table below. 1 Year 2 Year 3 Year Abstain Broker Non-Votes 89,272,772 120,361 1,610,822 97,888 10,459,292”

ALBEMARLE CORP shareholders approved Advisory vote on executive compensation at the 2023-05-02 meeting.

“Proposal 2 . Advisory vote on executive compensation . The shareholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers, by the votes set forth in the table below. Voted For Voted Against Abstain Broker Non-Votes 83,616,589 5,332,694 2,152,560 10,459,292”

ALBEMARLE CORP shareholders approved Election of directors at the 2023-05-02 meeting.

“Proposal 1 . Election of directors . The shareholders elected all of the nominees for director to serve for a term expiring at the annual meeting of shareholders in 2024, by the votes set forth in the table below. Nominees Voted For Voted Against Abstain Broker Non-Votes M. Lauren Brlas 87,349,454 3,681,646 70,743 10,459,292 Ralf H. Cramer 89,974,567 1,051,104 76,172 10,459,292 J. Kent Masters, Jr. 87,027,649 4,000,788 73,406 10,459,292 Glenda J. Minor 89,487,591 1,541,908 72,344 10,459,292 James J. O’Brien 87,168,233 3,856,539 77,071 10,459,292 Diarmuid B. O'Connell 88,848,884 2,175,572 77,387 10,459,292 Dean L. Seavers 88,545,434 2,478,357 78,052 10,459,292 Gerald A. Steiner 89,347,622 1,674,900 79,321 10,459,292 Holly A. Van Deursen 89,667,909 1,362,024 71,910 10,459,292 Alejandro D. Wolff 86,995,363 4,028,263 78,217 10,459,292”

ALBEMARLE CORP reported FY 2023 results: revenue $11.3 - $12.9 billion, EPS $26.00 - $33.00. Guidance initiated.

“Introducing 2023 Financial Targets FY 2023 Guidance as of Jan. 23, 2023 Net sales $11.3 - $12.9 billion Adjusted EBITDA $4.2 - $5.1 billion Adjusted EBITDA Margin 37% - 40% Adjusted Diluted EPS $26.00 - $33.00 Net Cash from Operations $2.1 - $2.4 billion Capital Expenditures $1.7 - $1.9 billion”

ALBEMARLE CORP reported Full Year 2022 results: revenue $7,290 - $7,350 million, net income $2,662 - $2,712 million.

“Fourth Quarter and Full-Year 2022 Preliminary Results Three Months Ended Year Ended December 31, December 31, In millions, except per share amounts 2022 2021 2022 2021 Net sales $2,590 - $2,650 $ 894.2 $7,290 - $7,350 $ 3,328.0 Net income (loss) attributable to Albemarle Corporation $1,107 - $1,157 $ (3.8) $2,662 - $2,712 $ 123.7”

ALBEMARLE CORP reported Fourth Quarter 2022 results: revenue $2,590 - $2,650 million, net income $1,107 - $1,157 million.

“Fourth Quarter 2022 Highlights (Unless otherwise stated, all percent changes represent year-over-year comparisons) • Net sales of between $2,590 million and $2,650 million, up 190% to 196% • Net income in the range of $1,107 million to $1,157 million • Diluted EPS of between $9.30 and $9.80 • Adjusted diluted EPS of between $8.35 and $8.75, up 727% to 766% • Adjusted EBITDA of between $1,210 million and $1,260 million, up 429% to 451%”

ALBEMARLE CORP reported the third quarter ended September 30, 2022 results: revenue $2.1 billion, net income $897.2 million, EPS $7.61 per diluted share.

“Net sales of $2.1 billion, an increase of 152%”

Karen G. Narwold departed as Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary at ALBEMARLE CORP.

“On October 25, 2022, Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary, Karen G. Narwold, advised the Board of Directors of Albemarle Corporation (the “Company”), that she will retire from the Company effective April 4, 2023.”

Karen G. Narwold departed as Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary at ALBEMARLE CORP.

“On October 25, 2022, Executive Vice President, Chief Administrative Officer, General Counsel and Corporate Secretary, Karen G. Narwold, advised the Board of Directors of Albemarle Corporation (the “Company”), that she will retire from the Company effective April 4, 2023.”

Ralf H. Cramer was appointed as Director at ALBEMARLE CORP.

“Effective as of February 21, 2022, the Board of Directors (the “Board”) of Albemarle Corporation (the “Company”), appointed Dr. Ralf H. Cramer as an independent member of the Board.”